![](/img/cover-not-exists.png)
Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signaling
Giltiay, Natalia V., Shu, Geraldine L., Shock, Anthony, Clark, Edward A.Volume:
19
Language:
english
Journal:
Arthritis Research & Therapy
DOI:
10.1186/s13075-017-1284-2
Date:
December, 2017
File:
PDF, 1.90 MB
english, 2017